Dr. Muss on the Impact of COVID-19 on Elderly Patients With Breast Cancer
April 27th 2020Hyman B. Muss, MD, sheds light on how the COVID-19 pandemic is impacting elderly patients with breast cancer and explains why geriatric patients are at a heightened risk of developing severe complications from the virus.
Read More
Dr. Murthy on the Clinical Implications of Tucatinib Approval in HER2+ Breast Cancer
April 22nd 2020Rashmi Murthy, MD, MBE, discusses the data that led to the approval of the tucatinib triplet, the clinical implications of the approval on practice, and the next steps for research with the agent.
Read More
Talking Tumors: Treating With Immunotherapy and Targeted Therapy in Lung Cancer
April 20th 2020Jyoti D. Patel, MD and Lawrence E. Feldman, MD, discuss second-line therapy in extensive-stage small cell lung cancer and the need for consolidative radiation, as well as the optimal sequence of therapy for a patient with non–small cell lung cancer who harbors a MET exon 14 mutation.
Read More
The State of Ovarian Cancer: Hot Topics in the COVID-19 Pandemic
April 17th 2020An OncLive® Weekly Webinar Series highlighting best practices, treatment updates, and multidisciplinary approaches to ovarian cancer care through the COVID-19 pandemic. Join us Wednesday, June 3, 2020 at 8 PM EST.
Read More
Sonpavde Navigates Newfound GU Cancer Treatment Considerations Amid COVID-19 Crisis
April 16th 2020Guru P. Sonpavde, MD sheds light on how the COVID-19 pandemic has impacted treatment decisions for patients with bladder cancer, perioperative surgical concerns for patients at risk of COVID-19, and the preventative measures Dana-Farber Cancer Institute has put into place to reduce the risk of patients and providers contracting the virus.
Read More
CAR T-Cell Therapy During the COVID-19 Pandemic: A Closer Look at Real-World Data
April 16th 2020This OncLive® webinar series will focus on the continued impact of the COVID-19 pandemic on the delivery of cellular therapeutics, particularly chimeric antigen receptor T cells. Join us Tuesday, May 19, 2020 at 8 PM EST.
Read More
The State of Ovarian Cancer: Exploring the Landscape of Systemic Therapy
April 16th 2020In this third webinar of our series, we will take an in-depth look at systemic therapy and how the landscape of treatment continues to evolve during this time. Join us on Wednesday, May 20, 2020 at 8 PM EST.
Read More
CAR T-Cell Therapy During the COVID-19 Pandemic: A Closer Look at Real-World Data
April 16th 2020This OncLive® webinar series will focus on the continued impact of the COVID-19 pandemic on the delivery of cellular therapeutics, particularly chimeric antigen receptor T cells. Join us Tuesday, May 19, 2020 at 8 PM EST.
Read More
Managing Lung Cancer Patients Through the COVID-19 Crisis: What to Know
April 15th 2020Join oncologists nationwide who have learned from the top leaders in the lung cancer field as they share their insights on coronavirus disease 2019 and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system. Join us Thursday, May 28, 2020 at 8 PM EST.
Read More
Physician and Patient Perspectives on Diagnosis and Treatment in Essential Thrombocythemia
April 14th 2020Ruben Mesa, MD, and his patient Antje Hjerpe, who has been living with essential thrombocythemia for 35 years, share the challenges in diagnosing ET, the current state of treatment and ongoing research efforts, and resources Mesa recommends on educating both physicians and patients on myeloproliferative neoplasms and components of care.
Read More
Managing Lung Cancer Patients Through the COVID-19 Pandemic: What to Know
April 13th 2020Join top leaders in the lung cancer field as they share their insights on COVID-19 and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system on Thursday, May 14, 2020 at 8 PM EST.
Read More